U K
The information below comes from the
UK Activity Report.
GeneMedix has received a £32m cash injection from Reliance Life Sciences to secure the future of its Newmarket-based drugs development business. 03-Jan-2007
GeneMedix is planning to restructure its Suffolk-based biopharmaceuticals business, in order to raise cash to pay off debts and secure its future. 10-Oct-2005
GeneMedix, the generic drug developer, is in takeover talks with a potential partner that would provide marketing opportunities in the US and Europe. 17-Feb-2004
GeneMedix is looking to open additional production plants in Asia and eastern Europe, as part of a strategy to double the size of its portfolio of generic drugs. 29-Aug-2002
GeneMedix is planning to spend £7.4m upgrading its generic drug production sites in China and Ireland and adding a third plant in east Asia. 22-Aug-2001
B U
S I N E S S
P A
R K
home page
Click here for further details
GeneMedix
The information above comes from the
UK Activity Report
Copyright UK Business Park 1995-2007